VRDN
Viridian Therapeutics Inc
NASDAQ · Biotechnology
$29.25
+0.08 (+0.27%)
Performance
1D
—
1W
-11.90%
1M
-10.19%
3M
+2.88%
6M
+55.17%
1Y
+62.68%
YTD
-4.66%
Open$30.14
Previous Close$29.17
Day High$30.17
Day Low$28.94
52W High$34.29
52W Low$9.90
Volume1.94M
Avg Volume1.57M
Market Cap2.94B
P/E Ratio—
EPS$-3.72
SectorBiotechnology
Volume Analysis
1.24x average volume
Technical Indicators
SMA 50
$31.95
Below
SMA 200
$21.82
Above
RSI (14)
23.2
Oversold
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
24 analysts
Price Target
+118.3% upside
Current
$29.25
$29.25
Target
$63.84
$63.84
$43.31
$63.84 avg
$68.31
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 441.6K | 945.1K | 406.82M |
| Net Income | -399,135,280 | -768,717,637 | -22,289,343 |
| Profit Margin | -89,387.1% | -84,917.7% | -5.5% |
| EBITDA | -441,402,567 | -897,351,676 | -26,538,842 |
| Free Cash Flow | — | — | -14,865,013 |
| Rev Growth | -53.3% | -53.3% | +16.2% |
| Debt/Equity | 0.03 | 0.03 | 0.29 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |